id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-0163-0003,FDA,FDA-2019-N-0163,"Hospira, Inc., et al.; Withdrawal of Approval of Six Abbreviated New Drug Applications",Notice,Withdrawal,2019-11-29T05:00:00Z,2019,11,2019-11-29T05:00:00Z,,2019-11-29T19:16:15Z,2019-25901,0,0,09000064841c88a9
FDA-2019-N-0163-0002,FDA,FDA-2019-N-0163,"Hospira, Inc., et al.; Withdrawal of Approval of 12 Abbreviated New Drug
Applications",Notice,Withdrawal,2019-06-14T04:00:00Z,2019,6,2019-06-14T04:00:00Z,,2019-06-14T13:17:37Z,2019-12560,0,0,0900006483d11ad2
FDA-2019-N-0163-0001,FDA,FDA-2019-N-0163,"Hospira, Inc., et al.; Withdrawal of Approval of 12 Abbreviated New Drug
Applications",Notice,Withdrawal,2019-02-12T05:00:00Z,2019,2,2019-02-12T05:00:00Z,,2019-02-12T14:05:00Z,2019-02032,0,0,0900006483a660cd